Status:
TERMINATED
Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients
Lead Sponsor:
Institut de Recherches Internationales Servier
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
55+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to demonstrate a long term efficacy of S18986 versus placebo on episodic memory performance in patients with MCI
Eligibility Criteria
Inclusion
- Memory complaint
- Acetylcholinesterase inhibitors stopped at least 3 months before selection
Exclusion
- Dementia
- Parkinson's disease
- Vascular disorder
- Depression
- Epilepsy
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 29 2006
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT00202540
Start Date
June 1 2005
End Date
March 29 2006
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital la Grave-Casselardit
Toulouse, France, 31000